Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational study of intravenous azithromycin in acute exacerbation of fibrosing interstitial pneumonia
jRCT1090220095Completed
- Sponsor
- Saiseikai Kumamoto Hospital
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azithromycin in Fibrosing interstitial pneumonia (FIP), sponsored by Saiseikai Kumamoto Hospital. Primary endpoint: 60-day survival from admission. Started Aug 2012; status: completed.
02
Drugs
azithromycin
03
Conditions
Fibrosing interstitial pneumonia (FIP)
Beyond the preview
Go deeper on jRCT1090220095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220095.